Anbio Biotechnology (NNNN)
NASDAQ: NNNN · Real-Time Price · USD
16.64
+0.78 (4.92%)
At close: Jun 18, 2026, 4:00 PM EDT
16.80
+0.16 (0.96%)
After-hours: Jun 18, 2026, 7:45 PM EDT
Anbio Biotechnology Market Cap
Anbio Biotechnology has a market cap or net worth of $730.35 million as of June 18, 2026. Its market cap has increased by 97.86% in one year.
Market Cap
730.35M
Enterprise Value
718.45M
1-Year Change
97.86%
Ranking
Category
Stock Price
$16.64
Market Cap Chart
Since the IPO on February 19, 2025, Anbio Biotechnology's market cap has increased from $219.46M to $730.35M, an increase of 232.80%. That is a compound annual growth rate of 147.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 730.35M | -44.66% |
| Dec 31, 2025 | 1.32B | 501.40% |
| Feb 19, 2025 | 219.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DENTSPLY SIRONA | 2.01B |
| Pulse Biosciences | 1.75B |
| STAAR Surgical Company | 1.45B |
| Alamar Biosciences | 1.40B |
| AtriCure | 1.37B |
| BioLife Solutions | 1.25B |
| Kestra Medical Technologies | 1.11B |
| Azenta | 1.05B |